Microemulsions as a surrogate carrier for dermal drug delivery

Drug Development and Industrial Pharmacy

Volumn 35, Issue 5, 2009, Pages 525-547

  Azeem, Adnan ^a   Khan, Zeenat Iqbal ^a   Aqil, M ^a   Ahmad, Farhan Jalees ^a   Khar, Roop Kishan ^a   Talegaonkar, Sushama ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Drug solubilization; Microemulsion; Permeation; Skin; Surfactants; Tolerability; Transdermal drug delivery

Indexed keywords

APOMORPHINE; CELECOXIB; CLINDAMYCIN PHOSPHATE; CYCLOSPORIN A; DICLOFENAC; DIPHENHYDRAMINE; EMLA; ESTRADIOL; FELODIPINE; FINASTERIDE; FLUOROURACIL; GLICLAZIDE; KETOPROFEN; LIDOCAINE; LINOLEIC ACID; MELOXICAM; METHOTREXATE; MICONAZOLE NITRATE; MYRISTIC ACID ISOPROPYL ESTER; NALOXONE; NIMESULIDE; OLEIC ACID; OXAPROZIN; PALMITIC ACID ISOPROPYL ESTER; PROGESTERONE; PROPRANOLOL; RIBAVIRIN; SALICYLIC ACID; TETRACAINE; TRIPTOLIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLTRAN EMULGEL; DRUG CARRIER;

ACNE VULGARIS; CHEMICAL COMPOSITION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; HYDROPHILICITY; IN VIVO STUDY; LIPOPHILICITY; MICROEMULSION; NONHUMAN; PARTICLE SIZE; REVIEW; SKIN; SKIN IRRITATION; SKIN PERMEABILITY; SURFACE TENSION; THERMODYNAMICS; TOXICITY TESTING; ANIMAL; CHEMISTRY; EMULSION; KINETICS; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; KINETICS; SKIN ABSORPTION;

EID: 67049160105     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802448646     Document Type: Review

References (234)

1. Aboofazeli, R., Lawrence, C. B., Wicks, S. R., & Lawrence, M. J. (1994). Investigations into the formation and characterization of phospholipid microemulsions III. Pseudo-ternary phase diagrams of systems containing water-lecithin-isopropyl myristate and either an alkanoic acid, amine, alkanediol, poly ethylene glycol alkyl ether or alcohol as co-surfactant. Int. J. Pharm., 111, 63-72.
2. Aboofazeli, R., Zia, H., & Needham, T. E. (2002). Transdermal delivery of nicardipine: An approach to in vitro permeation enhancement. Drug Deliv., 9, 239-247.
3. Akoh, C. C. (1992). Emulsification properties of polyesters and sucrose ester blends: Carbohydrates and fatty acid polyesters. J. Am. Oil Chem. Soc., 69, 9-19.
4. Alvarez-Figueroa, M. J., & Blanco-Mendez, J. (2001). Transdermal delivery of methotrexate: Iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int. J. Pharm., 215, 57-65.
5. Ambade, K. W., Jadhav, S. L., Gambhire, M. N., Kurmi, S. D., Kadam, V. J., & Jadhav, K. R. (2008). Formulation and evaluation of flurbiprofen microemulsion. Curr. Drug Deliv., 5, 32-41.
6. Andersson, M., & Lofroth, J.-E. (2003). Small particles of a heparin/chitosan complex prepared from a pharmaceutically acceptable microemulsion. Int. J. Pharm., 257, 305-309.
7. Araaya, H., Tomitab, M., & Hayashib, M. (2005). The novel formulation design of o/w microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds. Int. J. Pharm., 305, 61-74.
8. Asua, J. M. (2002). Miniemulsion polymerization. Prog. Polym. Sci., 27, 1283-1346.
9. Attwood, D. (1994). Microemulsions. In J. Kreuter (Ed.), Colloidal drug delivery systems (pp. 31-71). New York: Marcel Dekker.
10. Attwood, D., & Ktistis, G. (1989). A light scattering study on oil-in-water microemulsions. Int. J. Pharm., 52, 165-171.
11. Attwood, D., Mallon, C., Ktistis, G., & Taylor, C. J. (1992). A study on factors influencing the droplet size in nonionic oil-in-water microemulsions. Int. J. Pharm., 88, 417-422.
12. Aungst, B. J. (1989). Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm. Res., 6, 244-247.
13. Aungst, B. J., Rogers, N. J., & Shefter, E. (1986). Enhancement of naloxone permeation through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm., 33, 225-234.
14. Baran, R. J., & Wade, W. H. (1995). Temperature insensitive microemulsion phase behavior with non-ionic surfactants. J. Dispers. Sci. Technol., 16, 165.
15. Baroli, B., Lopez-Quintela, M. A., Delgado-Charro, M. B., Fadda, A. M., & Blanco-Mendez, J. (2000). Microemulsions for topical delivery of 8- methoxsalen. J. Control. Release, 69, 209-218.
16. Barry, B. W. (1987). Mode of action of penetration enhancers in human skin. J. Control. Release, 6, 85-97.
17. Barry, B. W. (2001). Is transdermal drug delivery still important today? Drug Discov. Today, 6, 967-971.
18. Benson, H. A. E. (2005). Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv., 2, 23-33.
19. Bhargava, H. N., Narurkar, A., & Lieb, L. M. (1987). Using microemulsions for drug delivery. Pharm. Tech., 11, 46-52.
20. Biju, S. S., Ahuja, A., & Khar, R. K. (2005). Tea tree oil in follicular cats after topical delivery: Determination by high performance thin layer chromatography using a perfused bovine udder model. J. Pharm. Sci., 94, 240-245.
21. Biruss, B., Kahlig, H., & Valenta, C. (2007). Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones. Int. J. Pharm., 328, 142-151.
22. Bodnar, I., Floter, E., Hogervorst, W., & Van Oosten, C. W. (2004). Microemulsions. US Patent No. 6716473.
23. Boltri, L., Morel, S., Trotta, M., & Gasco, M. R. (1994). In vitro transdermal permeation of nifedipine from thickened microemulsions. J. Pharm. Belg., 49, 315-320.
24. Bolzinger, M. A., Carduner, T. C., & Poelman, M. C. (1998). Bicontinuous sucrose ester microemulsion: A new vehicle for topical delivery of niflumic acid. Int. J. Pharm., 176, 39-45.
25. Bonina, F. P., Carelli, V., Di Colo, G., Montenegro, L., & Nannipieri, E. (1993). Vehicle effects on in vitro skin permeation of and stratum corneum affinity for model drugs caffeine and testosterone. Int. J. Pharm., 100, 41-48.
26. Bonina, F. P., Montenegro, L., Scrofani, N., Esposito, E., Cortesi, R., Menegatti, E., & Nastruzzi, C. (1995). Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate. J. Control. Release, 34, 53-63.
27. Burnett, G. R., Rees, G. D., Steytler, D. C., & Robinson, B. H. (2004). Fluorescence correlation spectroscopy of water-in-oil microemulsions: An application in specific characterization of droplets containing biomolecules. Colloids Surf. A Physicochem. Eng. Asp., 250, 171-178.
28. Carlfors, J., Blute, I., & Schmidt, V. (1991). Lidocaine in microemulsion-a dermal delivery system. J. Dispers. Sci. Technol., 12, 467-482.
29. Ceschel, G. C., Bergamante, V., Maffei, P., Borgia, S. L., Calabrese, V., & Biserni, S. (2005). Solubility and transdermal permeation properties of dehydoepiandrosterone cyclodextrin complex from hydrophilic and lipophilic vehicles. Drug Deliv., 12, 275-280.
30. Cevc, G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev., 56, 675-711.
31. Cevc, G., & Blume, G. (2001). New highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta, 1514, 191-205.
32. Changez, M., Chander, J., & Dinda, A. K. (2006a). Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: In vivo. Colloids Surf. B Biointerfaces, 48, 58-66.
33. Changez, M., Varshney, M., Chander, J., & Dinda, A. K. (2006b). Effect of the composition of lecithin/n-propanol/isopropylmyristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: In vitro. Colloids Surf. B Biointerfaces, 50, 18-25.
34. Chen, H., Chang, X., Weng, T., Zhao, X., Gao, Z., Yang, Y., Xu, H., & Yang, X. (2004). A study of microemulsion systems for transdermal delivery of triptolide. J. Control. Release, 98, 427-436.
35. Choi, M. J., & Maibach, H. I. (2005). Elastic vesicles as topical/transdermal drug delivery systems. Int. J. Cosmet. Sci., 27, 211-221.
36. Chung, S. L., Tan, C.-T., Tunhill, I. M., & Scharpf, L. G. ( 1994). Transparent oil-in-water microemulsion flavor or fragrance concentrate, process for preparing same, mouthwash or perfume composition containing said transparent microemulsion concentrate, and process for preparing same. US Patent No. 5283056.
37. Constantinides, P. P., & Yiv, S. H. (1995). Particle size determination of phase-inverted water-in-oil microemulsions under different dilution and storage conditions. Int. J. Pharm., 115, 225-234.
38. Cooper, E. R. (1984). Increased skin permeability for lipophilic molecules. J. Pharm. Sci., 73, 1153-1156.
39. Crook, D. (1997). The metabolic consequences of treating post menopausal women with non-oral hormone replacement therapy. Br. J. Obstet. Gynaecol., 104(Suppl. 16), 4-13.
40. Dalmora, M. E., Dalmora, S. L., & Oliveira, A. G. (2001). Inclusion complex of piroxicam with ?-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect. Int. J. Pharm., 222, 45-55.
41. Danielsson, I., & Lindman, B. (1981). The definition of microemulsion. Colloids Surf., 3, 391-392.
42. Danino, D., Gupta, R., Satyavolu, J., & Talmon, Y. (2002). Direct Cryogenictemperature transmission electron microscopy imaging of phospholipids aggregates in soybean oil. J. Colloid Interface Sci., 249, 180-186.
43. Danino, D., Talmon, Y., & Zana, R. (2002). Cryo-TEM of thread like micelles: On the grid microstructural transformations induced during specimen preparation. Colloids Surf. A Physicochem. Eng. Asp., 169, 67-73.
44. Davis, A. F., & Hadgraft, J. (1991). Effect of supersaturation on membrane transport of hydrocortisone acetate. Int. J. Pharm., 76, 1-8.
45. Dayan, N., & Touitou, E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes. Biomaterials, 21, 1879-1885.
46. D'Cruz, O. J., & Uckun, F. M. (2001). Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles. Contraception, 64, 113-123.
47. D'Cruz, O. J., Yiv, S. H., & Uckun, F. M. (2001). GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion. AAPS PharmSciTech, 2, E5.
48. Delgado-Charro, M. B., Iglesias-Vilas, G., Blanco-Mendez, J., Lopez-Quintela, M. A., & Guy, R. H. (1997). Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm., 43, 37-42.
49. Denet, A.-R., Vanbever, R., & Preat, V. (2004). Skin electroporation for topical and transdermal delivery. Adv. Drug Deliv. Rev., 56, 659-674.
50. Derle, D. V., Sagar, B. S. H., Kotwal, R. S., Ingole, R. D., & Chauhan, S. S. (2006a). A comparative in vitro evaluation of transdermal permeation of valdecoxib and its complex with HP-?-cyclodextrin from microemulsion based gel. Indian Drugs, 43, 625-629.
51. Derle, D. V., Sagar, B. S. H., & Pimpale, R. (2006b, September-October). Microemulsion as a vehicle for transdermal permeation of nimesulide. Indian J. Pharm. Sci., 68, 622-625.
52. Djordjevic, L., Primorac, M., Stupar, M., & Krajisnik, D. (2004). Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int. J. Pharm., 271, 11-19.
53. Dreher, F., Walde, P., Walther, P., & Wehrli, E. (1997). Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J. Control. Release, 45, 131-140.
54. Dungan, S. R. (1997). Microemulsions in foods: Properties and applications. In C. Solans & H. Kuneida (Eds.), Industrial applications of microemulsions. (p. 148). New York: Marcel Dekker.
55. Eccleston, J. (1994a). Microemulsions. In J. Kreuter (Ed.), Colloidal drug delivery systems (pp. 31-71). New York: Marcel Dekker.
56. Eccleston, J. (1994b). Microemulsions. In J. Swarbrick & J. C. Boylan (Eds.), Encyclopedia of pharmaceutical technology (pp. 375-421). New York: Marcel Dekker.
57. El Laithy, H. M., & El Shaboury, K. M. F. (2002). The development of cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS PharmSciTech, 3, 1-9.
58. Elena, P., Paola, S., & Maria, R. G. (2001). Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int. J. Pharm., 226, 47-51.
59. ElMaghraby, G. M. (2008). Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int. J. Pharm., 355, 285-292.
60. Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., & Khalafallah, N. M. (2006). Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery. Int. J. Pharm., 322, 60-66.
61. Engstrom, S., & Larsson, K. (1999). Microemulsions in foods. In P. Kumar & K. L. Mittal (Eds.), Handbook of microemulsion science and technology (p. 789). New York: Marcel Dekker.
62. Escribano, E., Calpena, A. C., Queralt, J., Obach, R., & Domenech, J. (2003). Assessment of diclofenac permeation with different formulations: Antiinflammatory study of a selected formula. Eur. J. Pharm. Sci., 19, 203-210.
63. Fang, J.-Y., Hwang, T.-L., Hwang, Y.-L., & Fang, C.-L. (2006). Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int. J. Pharm., 310, 131-138.
64. Fang, J.-Y., Leu, Y.-L., Chang, C.-C. (2004). Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Del., 11, 97-105.
65. Fang, J.-Y., Yu, S. Y., Wu, P. C., Huang, Y. B., & Tsai, Y. H. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharm., 215, 91-99.
66. Fanun, M., Wachtel, E., Antalek, B., Aserin, A., Hoffman, R. E., & Garti, N. (2001). A study of the microstructure of four-component sucrose ester microemulsions by SAXS and NMR. Colloids Surf. A Physicochem. Eng. Asp., 180, 173-186.
67. Fialho, S. L., & Da Silva-Cunha, A. (2004). New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin. Exp. Ophthalmol., 32, 626-632.
68. Fiume, M. Z. (2001). Final report on the safety assessment of lecithin and hydrogenated lecithin. Int. J. Toxicol., 20, 21-45.
69. Flynn, G. L. (1990). Physicochemical determinant of skin absorption. In T. R. Gerrity & C. J. Henry (Eds.), Principles of route-to-route extrapolation for risk assessment (pp. 93-127). New York: Elsevier.
70. Friend, D., Catz, P., Heller, J., Reid, J., & Baker, R. (1988). Transdermal delivery of levonorgestrel. J. Control. Release, 7, 243-250.
71. Gallarate, M., Carlotti, M. E., Trotta, M., & Bovo, S. (1999). On the stability of ascorbic acid in emulsified systems for topical and cosmetic use. Int. J. Pharm., 188, 233-241.
72. Garcia-Celma, M. J., Azemar, N., Pes, M. A., & Solans, C. (1994). Solubilization of antifungal drugs in water/POE(20) sorbitan monooleate/oil systems. Int. J. Pharm., 105, 77-81.
73. Gasco, M. R. (1997). Microemulsions in the pharmaceutical field: Perspectives and applications. In C. Solans & H. Kuneida (Eds.), Industrial applications of microemulsions (pp. 98-120). New York: Marcel Dekker.
74. Gattefosse Corporation. (1982). Company information material. New York: Elmsford.
75. Getei, M., Wohlrab, J., & Neubert, R. H. H. (2005). Dermal delivery of desmopressin acetate using colloidal carrier systems. J. Pharm. Pharmacol., 57, 423-427.
76. Ghosh, P. K., & Murthy, R. S. R. (2006). Microemulsions: A potential drug delivery system. Curr. Drug Deliv., 3, 167-180.
77. Gilje, E., Sonerson, L., Hollberg, P. E., Holmberg, K., & Svennberg, S. (1992). Norwegian Patent Nos.170411 and 17097.
78. Gillberg, G. (1984). In K. J. Lissant (Ed.), Emulsions and emulsion technology (pp. 1-43). New York: Marcel Dekker.
79. Glatter, O., Orthaber, D., Stradner, A., Scherf, G., Fanun, M., Garti, N., Clement, V., & Leser, M. E. (2001). Sugar-ester nonionic microemulsion: Structural characterization. J. Colloid Interface Sci., 241, 215-225.
80. Godwin, D. A., Kim, N.-H., & Feltan, L. A. (2002). Influence of transcutol® CG on the skin accumulation and transdermal permeation of ultraviolet absorbers. Eur. J. Pharm. Biopharm., 53, 23-27.
81. Goodman, M., & Barry, B. W. (1989). Lipid-protein-partitioning theory of skin enhancer activity: Finite dose technique. Int. J. Pharm., 57, 29-40.
82. Graf, A., Ablinger, E., Peters, S., Zimmerb, A., Hooka, S., & Rades, T. (2008). Microemulsions containing lecithin and sugar-based surfactants: Nanoparticle templates for delivery of proteins and peptides. Int. J. Pharm., 350, 351-360.
83. Guo, H., Liu, Z., Li, J., Nie, S., & Pan, W. (2006). Effect of isopropyl palmitate on the skin permeation of drugs. Biol. Pharm. Bull., 29, 2324-2326.
84. Gupta, R. R., Jain, S. K., & Varshney, M. (2005). AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5- fluorouracil. Colloids Surf. B Biointerfaces, 41, 25-32.
85. Guy, R. H. (1996). Current status and future prospects of transdermal drug delivery. Pharm Res., 13, 1765-1769.
86. Guy, R. H. (1998). Iontophoresis-recent developments. J. Pharm. Pharmacol., 50, 371-374.
87. Habe, A., & Keipert, S. (1997). Development and characterization of microemulsions for ocular application. Eur. J. Pharm. Biopharm., 43, 179-183.
88. Heard, C. M., Kung, D., & Thomas, C. P. (2006). Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the 'pull effect'. Int. J. Pharm., 321, 167-170.
89. Hellweg, T. (2002). Phase structure of microemulsions. Curr. Opin. Colloid Interface Sci., 7, 50-56.
90. Henry, S., Mc Allister, D. V., Allen, M. G., & Prausnitz, M. R. (1998). Microfabricated needles: A novel approach to transdermal drug delivery. J. Pharm. Sci., 87, 922-925. (Pubitemid 28381247)
91. Herold, A. E., Beardmore, R. A., & Parrish, S. K. ( 2004). Herbicide microemulsion- forming-concentrates, microemulsions, and methods, US Patent No. 6803345.
92. Hill, K., & Rhode, O. (1999). Sugar-based surfactants for consumer products and technical applications. Fett-Lipid, 101, 25-33.
93. Ho, H., Chen, L. C., Chiang, H. S., Spur, B. P., Wong, P. Y. K., & Sheu, M. T. (1998, June 21-26). Proceedings of the 25th International Symposium on Controlled Release of Bioactive Materials, Las Vegas, p. 579.
94. Hua, L., Weisan, P., Jiayu, L., & Ying, Z. (2004). Preparation, evaluation and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev. Ind. Pharm., 30, 657-666. (Pubitemid 38924636)
95. Huang, Y. B., Lin, Y. H., Lu, T. M., Wang, R. J., Tsai, Y. H., & Wu, P. C. (2008). Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int. J. Pharm., 349, 206-211.
96. Jian, X., Ganzuo, L., Zhiqiang, Z., Guowei, Z., & Kejian, J. (2001). A study of the microstructure of CTAB/1-butanol/octane/water system by PGSE-NMR, conductivity and cryo-TEM. Colloids Surf. A Physicochem. Eng. Asp., 191, 269-278.
97. Jumma, M., & Muller, B. W. (1998). The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm., 163, 81-89.
98. Junyaprasert, V. B., Boonsaner, P., Leatwimonlak, S., & Boonme, P. (2007). Enhancement of the skin permeation of clindamycin phosphate by AerosolOT/ 1-butanol microemulsions. Drug Dev. Ind. Pharm., 33, 874-880.
99. Kaalia, Y. N., Naik, A., Garrison, J., & Guy, R. H. (2004). Iontophoretic drug delivery. Adv. Drug Deliv. Rev., 56, 619-658.
100. Kamal, M. A. H. M., Iimura, N., Nabekura, T., & Kitagawa, S. (2007). Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion. Chem. Pharm. Bull., 55, 368-371.
101. Kang, B. K., Chon, S. K., Kim, S. H., Jeong, S. Y., Kim, M. S., Cho, S. H., Lee, H. B., & Gilson, K. (2004). Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int. J. Pharm., 286, 147-156.
102. Kantarci, G., Ozguney, I., Karasulu, H. Y., Guneri, T., & Basdemir, G. (2005). In vitro permeation of diclofenac sodium from novel microemulsion formulations through rabbit skin. DDR, 65, 17-25.
103. Kantaria, S., Rees, G. D., & Lawrence, M. J. (1999). Gelatin stabilized microemulsion- based organogels: Rheology and application in iontophoretic transdermal drug delivery. J. Control. Release, 60, 355-365.
104. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., & Kazuyoshi, M. (2002). Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. J. Control. Release, 81, 65-74. (Pubitemid 34454850)
105. Kemken, J., Ziegler, A., & Muller, B. W. (1991a). Investigations into the pharmacodynamic effects of dermally administered microemulsions containing ?-blockers. J. Pharm. Pharmacol., 43, 679-684.
106. Kemken, J., Ziegler, A., & Muller, B. W. (1991b). Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: Comparison of microemulsions and matrix patches as vehicle. Methods Find. Exp. Clin. Pharmacol., 13, 361-365.
107. Kima, S. K., Leea, A. H., Leea, V. S., Leea, Y.-K., Kimb, C.-Y., Moonc, H. T., & Byuma, Y. (2005). A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int. J. Pharm., 298, 176-185.
108. Kirjavainen, M., Monkkonen, J., Saukkosaari, M., Valjakka-Koskela, R., Kiesvaara, J., & Urtti, A. (1999). Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J. Control. Release, 58, 207-214.
109. Koa, C. J., Kob, Y. J., Kim, D. M., & Park, H. J. (2003). Solution properties and PGSE-NMR self-diffusion study of C18:1 E10/oil/water system. Colloids Surf. A Physicochem. Eng. Asp., 216, 55-63.
110. Kogan, A., & Garti, N. (2006). Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci., 123-126, 369-385.
111. Kreilgaard, M. (2001). Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis. Pharm Res., 18, 367-373.
112. Kreilgaard, M. (2002). Influence of microemulsion on cutaneous drug delivery. Adv. Drug Deliv. Rev., 54, S77-S98. (Pubitemid 35379956)
113. Kreilgaard, M., Kemme, M. J., Burggraaf, J., Schoemaker, R. C., & Cohen, A. F. (2001). Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm Res., 18, 593-599.
114. Kreilgaard, M., Pedersen, E. J., & Jaroszewski, J. W. (2000). NMR characterization and transdermal drug delivery potential microemulsion systems. J. Control. Release, 69, 421-433.
115. Kriwet, K., & Muller-Goymann, C. C. (1995). Diclofenac release from phospholipids drug systems and permeation through excised human stratum corneum. Int. J. Pharm., 125, 231-242.
116. Ktistis, G. (1990). A viscosity study on oil-in-water microemulsions. Int. J. Pharm., 61, 213-218.
117. Ktistis, G., & Niopas, I. (1998). A study on the in-vitro percutaneous absorption of propranolol from disperse systems. J. Pharm. Pharmacol., 50, 413-418.
118. Kumar, P., & Mittal, K. L. (1999). Handbook of microemulsion science and technology. New York: Marcel Dekker.
119. Kumhar, S. K., Jain, S. K., Pancholi, S. S., Agrawal, S., Saraf, D. K., & Agrawal, G. P. (2003). Vesicular transdermal drug delivery system of ethinylestradiol and levonorgestrel for contraception and hormone replacement therapy. Indian J. Pharm. Sci., 65, 620-627.
120. Lam, A. C., & Schechter, R. S. (1987). The theory of diffusion in microemulsions. J. Colloid Interface Sci., 120, 56-63.
121. Lawrence, M. J. (1994). Surfactant systems: Microemulsions and vesicles as vehicles for drug delivery. Eur. J. Drug Metab. Pharmacokinet., 3, 257-269.
122. Lawrence, M. J. (1996). Microemulsions as drug delivery vehicles. Curr. Opin. Colloid Interface Sci., 1, 826-832.
123. Lawrence, M. J., & Rees, G. D. (2000). Microemulsion based media as novel drug delivery systems. Adv. Drug Deliv. Rev., 47, 89-121.
124. Lee, J., Lee, Y., Kim, J., Yoon, M., & Choi, Y. W. (2005). Formulation of microemulsion systems for transdermal delivery of aceclofenac. Arch. Pharm. Res., 28, 1097-1102.
125. Lehmann, L., Keipert, S., & Gloor, M. (2001). Effects of microemulsions on the stratum corneum and hydrocortisome penetration. Eur. J. Pharm. Biopharm., 52, 129-136.
126. Lianly, I. L., Nandi, I., & Kim, K. H. (2002). Development of an ethyl laurate based microemulsion for rapid onset of intranasal delivery of diazepam. Int. J. Pharm., 237, 77-85.
127. Linn, E. E., & York, T. O. (1989). Skin moisturizing microemulsions, US Patent No. 4797273.
128. Liu, J., Hu, W., Chen, H., Ni, Q., Xu, H., & Yang, X. (2007). Isotretinoin loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm., 328, 191-195.
129. Liu, H., Li, S., Wang, Y., Han, F., & Dong, Y. (2006). Bicontinuous water- AOT/Tween 85-isopropyl myristate microemulsion: A new vehicle for transdermal delivery of cyclosporine A. Drug Dev. Ind. Pharm., 32, 549-557.
130. Lopez, F., Cinelli, G., Ambrosone, L., Colafemmina, G., Ceglie, A., & Palazzo, G. (2004). Role of the cosurfactant in water-in-oil microemulsion: Interfacial properties tune the enzymatic activity of lipase. Colloids Surf. A Physicochem. Eng. Asp., 237, 49-59.
131. Lv, F.-F., Li, N., Zheng, L.-Q., & Tung, S.-H. (2006). Studies on the stability of the chloramphenicol in the microemulsion free of alcohols. Eur. J. Pharm. Biopharm., 62, 288-294.
132. Madhusudhan, B., Rambhau, D., Apte, S. S., & Gopinath, D. (2006). Improved in vitropermeation of nabumetone across rat skin from 1-O-alkylglycerol/ lecithin stabilized o/w nanoemulsions. J. Dispers. Sci. Technol., 27, 921-926.
133. Maestrelli, F., Gonzalez-Rodriguez, M. L., Rabasco, A. M., & Mura, P. (2006). Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int. J. Pharm., 312, 53-60.
134. Magdassi, S., Ben Moshe, M., Talmon, Y., & Danino, D. (2003). Microemulsion based on anionic Gemini surfactant. Colloids Surf. A Physicochem. Eng. Asp., 212, 1-7.
135. Malcolmson, C., & Lawrence, M. J. (1990). A comparison between nonionic micelles and microemulsions as a means of incorporating the poorly water soluble drug diazepam. J. Pharm. Pharmacol., 42 (Suppl.), 6.
136. Malcolmson, C., & Lawrence, M. J. (1993). Comparison of the incorporation of model steroids into non-ionic micellar and microemulsion systems. J. Pharm. Pharmacol., 45, 141-143.
137. Malcolmson, C., Satra, C., Kantaria, S., Sidhu, A., & Lawrence, M. J. (1998). Effect of oil on the level of solubilization of testosterone propionate into non-ionic oil-in-water microemulsions. J. Pharm. Sci., 87, 109-116.
138. Manosroi, A., Kongkaneramit, L., & Manosroi, J. (2004). Stability and transdermal absorption of topical amphotericin B liposome formulations. Int. J. Pharm., 70, 279-286.
139. Marszall, L. (1987). HLB of nonionic surfactants: PIT and EIP methods. In M. J. Schick (Ed.), Nonionic surfactant: Physical chemistry (pp. 493-547). New York: Marcel Dekker.
140. Megrab, N. A., Williams, A. C., & Barry, B. W. (1995). Oestradiol permeation across human skin, silastic and snake skin membranes: The effects of ethanol/ water cosolvent systems. Int. J. Pharm., 116, 101-112.
141. Mei, Z., Chen, H., Weng, T., Yang, Y., & Yang, X. (2003). Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm., 56, 189-196.
142. Mitragotri, S., Edwards, D. A., Blankschtein, D., & Langer, R. (1995). A mechanistic study of ultrasonically enhanced transdermal drug delivery. J. Pharm. Sci., 84, 697-706.
143. Mohammed, C., & Manoj, V. (2000). Aeosol-OT microemulsions as transdermal carriers of tetracaine hydrochloride. Drug Dev. Ind. Pharm., 26, 507-512.
144. Morimoto, Y., Sugibayashi, K., Kobayashi, D., Shoji, H., Yamazaki, J.-I., & Kimura, M. (1993). A new enhancer-coenhancer system to increase skin permeation of morphine hydrochloride in vitro. Int. J. Pharm., 91, 9-14.
145. Moulik, S. P., & Paul, B. K. (1998). Structure, dynamics and transport properties of microemulsions. Adv. Colloid Interface Sci., 78, 99-195.
146. Mrestani, Y., El-Mokdad, N., Ruttinger, H. H., & Neubert, R. H. H. (1998a). Characterization of partitioning behaviour of cephalosporins using microemulsion and micellar electrokinetic chromatography. Electrophoresis, 19, 2895-2899.
147. Mrestani, Y., Neubert, R. H. H., & Krause, A. (1998b). Partition behaviour of drugs in microemulsions measured by electrokinetic chromatography. Pharm. Res., 15, 799-801.
148. Mueller, B. W., & Mueller, R. H. (1984). Particle size distributions and particle size alterations in microemulsions. J. Pharm. Sci., 73, 919-922.
149. Muller, R. H., Radtke, M., & Wissing, S. A. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev., 54, S131-S155.
150. Myers, D. (1999). Surfaces, interfaces and colloids. New York: Wiley.
151. Narayanan, K. S., & Jon, D. I. ( 2003). Water miscible emulsions of pyrethroid insecticides or triazole fungicides, US Patent No. 6541516.
152. Neubert, R. H., Schmalfuss, U., Wolf, R., & Wohlrab, W. A. (2005). Microemulsions as colloidal vehicle systems for dermal drug delivery. Part V: Microemulsions without and with glycolipid as penetration enhancer. J. Pharm. Sci., 94, 821-827.
153. Obata, Y., Takayama, K., Maitani, Y., Machida, Y., & Nagai, T. (1993). Effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int. J. Pharm., 89, 191-198.
154. Ogiso, T., & Shintani, M. (1990). Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J. Pharm. Sci., 79, 1065-1071.
155. Okabe, H., Suzuki, E., Saitoh, T., Takayama, K., & Nagai, T. (1994). Development of novel transdermal system containing d-limonene and ethanol as absorption enhancers. J. Control. Release, 32, 243-247.
156. Ongpipattanakul, B., Burnette, R., & Potts, R. O. (1991). Evidence that oleic acid exists as a separate phase within stratum corneum. Pharm. Res., 8, 350-354.
157. Osborne, D. W., Ward, A. J., & O'Neill, K. J. (1988). Microemulsions as topical drug delivery vehicles: Part 1. Characterization of a model system. Drug Dev. Ind. Pharm., 14, 1202-1219.
158. Osborne, D. W., Ward, A. J., & O'Neill, K. J. (1991). Microemulsions as topical drug delivery vehicles: In vitro transdermal studies of a model hydrophilic drug. J. Pharm. Pharmacol., 43, 450-454.
159. Panchagnula, R., Salve, P. S., Thomas, N. S., Jain, A. K., & Ramarao, P. (2001). Transdermal delivery of naloxone: Effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int. J. Pharm., 219, 95-105.
160. Paolino, D., Ventura, C. A., Nistico, S., Puglisi, G., & Fresta, M. (2002). Lecithin microemulsions for the topical administration of ketoprofen: Percutaneous absorption through human skin and in vivo human skin tolerability. Int. J. Pharm., 244, 21-31.
161. Parikh, D. K., & Ghosh, T. K. (2005). Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech, 6, E144-E149.
162. Park, E. S., Cui, Y., Yun, B. J., Ko, I. J., & Chi, S. C. (2005). Transdermal delivery of piroxicam using microemulsions. Arch. Pharm. Res., 28, 243-248.
163. Payne, R. (1998). Factors influencing quality of life in cancer patients: The role of transdermal fentanyl in the management of pain. Semin. Oncol., 25, 47-53. (Pubitemid 28326225)
164. Pedersen, J. S. (1999). Analysis of small-angle scattering data from micelles and microemulsions: Free-form approaches and model fitting. Curr. Opin. Colloid Interface Sci., 4, 190-196.
165. Peimi, M. P. Y., Korner, D., Benita, S., & Marty, J.-P. (1999). Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J. Control. Release, 58, 177-187.
166. Peira, E., Carlotti, M. E., Trotta, C., Cavalli, R., & Trotta, M. (2008). Positively charged microemulsions for topical application. Int. J. Pharm., 346, 119-123.
167. Peira, E., Scolari, P., & Gasco, M. R. (2001). Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int. J. Pharm., 226, 47-51.
168. Peltola, S., Saarinen-Savolainen, P., Kiesvaara, J., Suhonen, T. M., & Urtti, A. (2003). Microemulsions for topical delivery of estradiol. Int. J. Pharm., 254, 99-107.
169. Pes, M. A., Atamaki, K., Nakamura, N., & Kuneida, H. (1993). Temperature insensitive microemulsions in a sucrose monoalkanoate system. J. Colloid Interface Sci., 178, 666.
170. Pineyro-Lopez, A., Pineyro-Garza, E., Torres-Alanis, O., Reyes-Araiza, R., Gomez-Silva, M., Waksman, N., Salazar-Leal, M. E., & Lujan-Rangel, R. (2007). Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin a microemulsion: A randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers. Clin. Ther., 29, 2049-2054.
171. Podlogar, F., Gasperlin, M., Tomsic, M., Jamnik, A., & Bester Rogac, M. (2004). Structural characterisation of water-Tween 40® /Inwitor 308® -isopropylmyristate microemulsions using different experimental methods. Int. J. Pharm., 276, 115-128.
172. Porras, M., Solans, C., Gonzalez, C., Martinez, A., Guinart, A., & Gutierrez, J. M. (2004). Studies of formation of w/o nanoemulsions. Colloids Surf. A Physicochem. Eng. Asp., 249, 115-118.
173. Potts, R. O., & Francoeur, M. L. (1990). Lipid biophysics of water loss through the skin. Proc. Natl Acad. Sci. USA, 87, 3871-3873.
174. Prausnitz, M. R. (2004). Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev., 56, 581-587.
175. Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004). Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov., 3, 115-124. (Pubitemid 38239773)
176. Priano, L., Albani, G., Brioschi, A., Calderoni, S., Lopiano, L., Rizzone, M., Cavalli, R., Gasco, M. R., Scaglione, F., Fraschini, F., Bergamasco, B., & Mauro, A. (2004). Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's disease. Mov. Disord., 19, 937-942.
177. Prince, L. M. (1977). Microemulsions: Theory and practice. New York: Academic Press.
178. Rhee, Y.-S., Choi, J.-G., Park, E.-S., & Chi, S.-C. (2001). Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm., 228, 161-170.
179. Sarpotdar, P. P., & Zatz, J. L. (1986). Evaluation of penetration
180. Savic, S. D., Savic, M. M., Vesic, S. A., Vuleta, G. M., & Muller-Goymann, C. C. (2006). Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation. Int. J. Pharm., 320, 86-95.
181. Schaefer, H., & Redelmeier, T. E. (1996). Skin barrier: Principles of percutaneous absorption. Basel: Karger.
182. Scheuplein, R. J., & Blank, I. H. (1971). Permeability of the skin. Physiol. Rev., 51, 702-747.
183. Schmalfuß, U., Neubert, R., & Wohlrab, W. (1997). Modification of drug penetration into human skin using microemulsions. J. Control. Release, 46, 279-285.
184. Schreier, H., & Bouwstra, J. (1994). Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. J. Control. Release, 30, 1-15.
185. Schurer, N. Y., & Elias, P. M. (1991). The biochemistry and function of stratum corneum lipids. Adv. Lipid Res., 24, 27-56.
186. Schulman, J. H., Stoeckenius, W., & Prince, L. M. (1959). Mechanism of formation and structure of microemulsions by electron microscopy. J. Phys. Chem., 63, 1677-1680.
187. Shafiq, S., Faiyaz, S., Sushma, T., Ahmad, F. J., Khar, R. K., & Ali, M. (2007) Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm., 66, 227-243. (Pubitemid 46667230)
188. Shafiq-un-Nabi, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., Khar, R. K., & Ali, M. (2007). Formulation development and optimization using nanoemulsion technique: A technical note. AAPS PharmSciTech, 8(2), E1-E6.
189. Shah, D. O. (1998). Micelles, microemulsions and monolayers: Science and technology. New York: Marcel Dekker.
190. Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Aqil, M., & Shafiq, S. (2007). Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech, 8(4), E1-E9.
191. Shevachman, M., Garti, N., Shani, A., & Sintov, A. C. (2008). Enhanced percutaneous permeability of diclofenac using a new U-type dilutable microemulsion. Drug Dev. Ind. Pharm., 34, 403-412.
192. Shinoda, K., & Lindman, B. (1987). Organised surfactant systems: Microemulsions. Langmuir, 3, 135-149.
193. Silas, J. A., & Kaler, E. W. (2001). The phase behavior and microstructure of efficient cationic-nonionic microemulsions. J. Colloid Interface Sci., 243, 248-254.
194. Silas, J. A., & Kaler, E. W. (2003). Effect of multiple scattering on SANS spectra from bicontinuous microemulsions. J. Colloid Interface Sci., 257, 291-298.
195. Sintov, A. C., & Brandys-Sitton, R. (2006). Facilitated skin penetration of lidocaine: Combination of a short-term iontophoresis and microemulsion formulation. Int. J. Pharm., 316, 58-67.
196. Sintov, A. C., & Shapiro, L. (2004). New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J. Control. Release, 95, 173-183.
197. Sjoblom, J., Lindberg, R., & Friberg, S. E. (1996). Microemulsions-phase equilibria characterization, structures, applications and chemical reactions. Adv. Colloid Interface Sci., 65, 125-287.
198. Sommerville, M. L., Cain, J. B., Johnson, C. S., Jr., & Hickey, A. J. (2000). Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants. Pharm. Dev. Technol., 5, 219-230.
199. Sonneville-Aubrun, O., Simonnet, J. T., & L'Alloret, F. (2004). Nanoemulsions: A new vehicle for skin care products. Adv. Colloid Interface Sci., 108-109, 145-149.
200. Souto, E. B., Wissing, S. A., Barbosa, C. M., & Muller, R. H. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm., 278, 71-77.
201. Spiclin, P., Gasperlin, M., & Kmetec, V. (2001). Stability of ascorbyl palmitate in topical microemulsions. Int. J. Pharm., 222, 271-279.
202. Spiclin, P., Homar, M., Zupancic-Valant, A., & Gasperlin, M. (2003). Sodium ascorbyl phosphate in topical microemulsions. Int. J. Pharm., 256, 65-73.
203. Stilbs, P., Lindman, B., & Rapacki, K. (1983). Effect of alcohol cosurfactant length on microemulsion structure. J. Colloid Interface Sci., 95, 583-585.
204. Stoughton, R. B., & Fritsch, W. (1964). Influence of dimethyl sulfoxide on human percutaneous absorption. Arch. Dermatol., 90, 512-517.
205. Stubenrauch, C. (2001). Sugar surfactants-aggregation, interfacial, and adsorption phenomena. Curr. Opin. Colloid Interface Sci., 6, 160-170.
206. Subramanian, N., Ghosal, S. K., & Moulik, S. P. (2005). Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev. Ind. Pharm., 31, 405-416.
207. Tanojo, H., Boelsma, E., Junginger, H. E., Ponec, M., & Bodde, H. E. (1999). In vivo human skin permeability enhancement by oleic acid: A laser Doppler velocimetry study. J. Control. Release, 58, 97-104.
208. Tanojo, H., Bowstra, J. A., Junginger, H. E., & Bodde, H. E. (1997). In vitro human skin barrier modulation by fatty acids: Skin permeation and thermal analysis studies. Pharm. Res., 14, 42-49. (Pubitemid 27113313)
209. Tenjarla, S. (1999). Microemulsions: An overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carrier Syst., 16, 461-521.
210. Thacharochi, D., & Rao, K. P. (1994). Transdermal absorption of nifedipine from microemulsions of lipophilic penetration enhancers. Int. J. Pharm., 111, 235-240.
211. Thomas, J. B., & Finnin, C. B. (2004). The transdermal revolution. Drug Discov. Today, 9, 697-703.
212. Touitou, E., Dayan, N., Bergelson, L., Godin, B., & Eliaz, M. (2000). Ethosomes- novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Control. Release, 65, 403-418.
213. Touitou, E., Godin, B., Karl, Y., Bujanover, S., & Becker, Y. (2002). Oleic acid, a skin penetration enhancer, affects Langerhans cells and corneocytes. J. Control. Release, 80, 1-7.
214. Trotta, M., Gasco, M. R., Caputo, O., & Sancin, P. (1994). Transcutaneous diffusion of hematoporphyrin in photodynamic therapy: In vitro release from microemulsions. STP Pharma. Sci., 4, 150-154.
215. Trotta, M., Gasco, M. R., & Pattarino, F. (1990). Diffusion of steroid hormones from o/w microemulsions: Influence of the cosurfactant. Acta Pharm. Technol., 36, 226-231.
216. Trotta, M., Morel, S., & Gasco, M. R. (1997). Effect of oil phase composition on the skin permeation of felodipine from w/o microemulsions. Pharmazie, 52, 50-53.
217. Trotta, M., Pattarino, F., & Gasco, M. R. (1996). Influence of counterions on the skin permeation of methotrexate from w/o microemulsions. Pharm. Acta Helv., 71, 135-140.
218. Trotta, M., Ugazio, E., Peira, E., & Pulitano, C. (2003). Influence of ion pairing on topical delivery of retinoic acid from microemulsions. J. Control. Release, 86, 315-321.
219. Turi, J. S., Danielson, D., & Woltersom, J. W. (1979). Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate. J. Pharm. Sci., 68, 275-280.
220. Uchegbu, I. F., & Vyas, S. P. (1998). Nonionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm., 172, 33-70.
221. Valenta, C., & Schultz, K. (2004). Influence of carrageenan on the rheology and skin permeation of microemulsion formulations. J. Control. Release, 95, 257-265.
222. Vanhal, D., Vanrensen, A., Devringer, T., Junginger, H., & Bouwstra, J. A. (1996). Diffusion of estradiol from non-ionic surfactant vesicles through human stratum corneum in vitro. STP Pharma. Sci., 6, 72-78.
223. von Corswant, C., Thoren, P., & Engstrom, S. (1998). Triglyceride based microemulsion for intravenous administration of sparingly soluble substances. J. Pharm. Sci., 87, 200-208.
224. Vora, B., Khopade, A. J., & Jain, N. K. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Control. Release, 54, 149-165.
225. Vyas, T. K., Babbar, A. K., Sharma, R. K., Singh, S., & Misra, A. (2005). Intranasal mucoadhesive microemulsions of clonazepam: Preliminary studies on brain targeting. J. Pharm. Sci., 95, 570-580.
226. Walker, R. B., & Smith, E. W. (1996). The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev., 18, 295-301.
227. Warisnoicharoen, W., Lansley, A. B., & Lawrence, M. J. (2000). Nonionic oilin- water microemulsions: The effect of oil type on phase behaviour. Int. J. Pharm., 198, 7-27.
228. Weaver, J. C., Vaughan, T. E., & Chizmadzhev, Y. (1999). Theory of electrical creation of aqueous pathways across skin transport barriers. Adv. Drug Deliv. Rev., 35, 21-39.
229. Williams, A. C., & Barry, B. W. (2004). Penetration enhancers. Adv. Drug Deliv. Rev., 56, 603-618.
230. Wu, H., Ramachandaran, C., Bielinska, A. U., Kingzett, K., Sun, R., Weiner, N. D., & Roessler, B. J. (2001). Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int. J. Pharm., 221, 23-34.
231. Wu, H., Ramachandaran, C., Weiner, N. D., & Roessler, B. J. (2001). Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int. J. Pharm., 220, 63-75.
232. Yuan, Y., Li, S.-M., Mo, F.-K., & Zhong, D.-F. (2006). Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm., 321, 117-123.
233. Zhao, X., Chen, D., Gao, P., Ding, P., & Li, K. (2005). Synthesis of Ibuprofen eugenol ester and its microemulsion formulation for parenteral delivery. Chem. Pharm. Bull., 53, 1246-1250. (Pubitemid 41425616)
234. Zhao, X., Liu, J. P., Zhang, X., & Li, Y. (2006). Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int. J. Pharm., 327, 58-64.